Currently, most medical treatments are provided to people?after?the onset of disease symptoms, regardless of their genetic background. As a result, people may receive treatments too late to be effective and, in some cases, unsuitable treatments are administered. Proprietary tests developed by Advanced Genetic Diagnostics, a participant in the CSIRO ON program, can be applied years?before?the development of chronic disease symptoms. Earlier treatment of high risk people could save lives. They are currently seeking investors to market their test across the globe.